
  
    
      
        Background_NNP
        The_DT popularity_NN of_IN complementary_JJ ,_, alternative_NN and_CC
        unconventional_JJ medicine_NN is_VBZ increasing_VBG worldwide_NN ._. Several_JJ
        surveys_NNS have_VBP estimated_VBN that_IN between_IN 30_CD and_CC 70_CD %_NN of_IN patients_NNS
        in_IN developed_VBN countries_NNS use_VBP these_DT practices_NNS ,_, depending_VBG on_IN
        the_DT population_NN and_CC modality_NN ._. [_NN 1_CD 2_CD 3_CD ]_NN There_EX is_VBZ ,_, however_RB ,_, a_DT
        paucity_NN of_IN scientific_JJ research_NN on_IN many_JJ complementary_JJ and_CC
        alternative_NN medical_JJ (_( CAM_NNP )_) practices_NNS ._. A_DT recent_JJ commentary_NN in_IN
        the_DT Archives_NNPS of_IN Internal_NNP Medicine_NNP (_( vol_NN ._. 156_CD ,_, pp_NN ._. 2162_CD -_: 2164_CD )_)
        called_VBN for_IN more_JJR research_NN into_IN one_CD of_IN the_DT most_RBS controversial_JJ
        of_IN these_DT practices_NNS ,_, homeopathy_NN ,_, to_TO determine_VB its_PRP$ quality_NN
        and_CC clinical_JJ efficacy_NN ,_, putting_VBG aside_RB for_IN the_DT moment_NN its_PRP$
        implausibility_NN ._.
        Over_IN the_DT past_JJ several_JJ decades_NNS there_RB have_VBP been_VBN a_DT number_NN
        of_IN clinical_JJ trials_NNS on_IN various_JJ forms_NNS of_IN homeopathic_JJ
        treatment_NN for_IN a_DT host_NN of_IN disorders_NNS from_IN stroke_NN and_CC
        post-operative_JJ complications_NNS to_TO arthritis_NN and_CC fibromyalgia_NN
        to_TO influenza_NN and_CC upper_JJ respiratory_JJ track_NN infections_NNS ._. [_NN 4_CD 5_CD
        ]_NN While_IN the_DT treatment_NN and_CC conditions_NNS studied_VBN vary_VBP ,_, they_PRP
        share_VBP the_DT common_JJ property_NN of_IN representing_VBG clinical_JJ outcome_NN
        research_NN on_IN forms_NNS of_IN homeopathic_JJ medicine_NN ._. Several_JJ
        independent_JJ systematic_JJ reviews_NNS published_VBN to_TO date_NN on_IN this_DT
        research_NN have_VBP all_DT shown_VBN a_DT surprising_JJ number_NN of_IN positive_JJ
        results_NNS ,_, even_RB among_IN those_DT trials_NNS that_WDT received_VBD high_JJ quality_NN
        ratings_NNS for_IN randomization_NN ,_, blinding_VBG ,_, sample_NN size_NN and_CC other_JJ
        methodological_JJ criteria_NNS ._. [_NN 4_CD 5_CD 6_CD ]_NN None_NN of_IN these_DT reviews_NNS ,_,
        however_RB ,_, have_VBP looked_VBN at_IN a_DT broad_JJ spectrum_NN of_IN validity_NN
        criteria_NNS and_CC none_NN have_VBP compared_VBN the_DT quality_NN of_IN homeopathic_JJ
        research_NN to_TO conventional_JJ research_NN using_VBG methods_NNS that_WDT were_VBD
        not_RB derived_VBN from_IN a_DT conventional_JJ clinical_JJ diagnostic_JJ
        framework_NN ._.
        A_DT number_NN of_IN authors_NNS have_VBP addressed_VBN the_DT difficulties_NNS
        encountered_VBD in_IN experimental_JJ studies_NNS of_IN homeopathy_NN ._. [_NN 5_CD 7_CD 8_CD
        9_CD 10_CD 11_CD 12_CD ]_NN While_IN these_DT issues_NNS have_VBP been_VBN extensively_RB
        discussed_VBN in_IN the_DT homeopathic_JJ literuature_NN ,_, the_DT issues_NNS are_VBP
        not_RB well_RB known_VBN in_IN the_DT conventional_JJ literature_NN ._. The_DT main_JJ
        issue_NN relevant_JJ to_TO assessment_NN of_IN research_NN quality_NN is_VBZ that_IN
        the_DT theoretical_JJ and_CC clinical_JJ approaches_NNS of_IN homeopathy_NN use_NN
        different_JJ diagnostic_JJ and_CC therapeutic_JJ taxonomies_NNS than_IN
        conventional_JJ medicine_NN ._. Unlike_IN conventional_JJ medicine_NN that_IN
        attempts_NNS to_TO isolate_VB cause_VB -_: effect_NN links_NNS between_IN single_JJ
        treatments_NNS and_CC specific_JJ diseases_NNS ,_, homeopathic_JJ medicine_NN
        focuses_VBZ on_IN the_DT stimulation_NN of_IN broad_JJ healing_NN processes_VBZ that_WDT
        have_VBP influences_VBZ on_IN a_DT variety_NN of_IN conditions_NNS and_CC symptom_NN
        patterns_NNS ._. [_NN 8_CD ]_NN Current_JJ classical_JJ homeopathic_JJ practitioners_NNS
        use_VBP complex_JJ pattern_NN recognition_NN procedures_NNS (_( often_RB computer_NN
        assisted_VBN )_) to_TO initiate_VB treatment_NN ,_, evaluate_VB patient_NN response_NN
        and_CC adjust_VB therapy_NN ._. It_PRP is_VBZ within_IN this_DT so-called_JJ "_'' holistic_JJ "_''
        paradigm_NN that_IN researchers_NNS continue_VBP to_TO attempt_VB a_DT critical_JJ
        examination_NN of_IN the_DT specific_JJ effects_NNS of_IN homeopathic_JJ
        therapies_NNS as_IN they_PRP relate_VBP to_TO conventional_JJ diagnostic_JJ
        categories_NNS ._. Lack_NN of_IN homeopathic_JJ expertise_NN by_IN researchers_NNS or_CC
        difficulties_NNS in_IN modification_NN of_IN homeopathic_JJ practice_NN goals_NNS
        to_TO fit_VB conventional_JJ diagnosis-based_JJ research_NN designs_NNS can_MD
        cause_VB confusion_NN in_IN the_DT design_NN and_CC execution_NN of_IN clinical_JJ
        trials_NNS and_CC in_IN the_DT evaluation_NN and_CC interpretation_NN of_IN results_NNS ._.
        For_IN example_NN ,_, a_DT study_NN by_IN Shipley_NNP on_IN the_DT treatment_NN of_IN
        osteoarthritis_NNS with_IN the_DT homeopathic_JJ remedy_NN 
        Rhus_NNP tox_NN reported_VBD no_DT difference_NN in_IN
        outcome_NN compared_VBN to_TO placebo_NN ._. [_NN 13_CD ]_NN The_DT method_NN for_IN
        identifying_VBG patients_NNS who_WP fit_VBP the_DT pattern_NN most_RBS likely_JJ to_TO
        respond_VB to_TO 
        Rhus_NNP tox_NN was_VBD crude_NN ,_, however_RB ,_,
        reflecting_VBG poor_JJ homeopathic_JJ practice_NN ._. A_DT follow-up_JJ study_NN by_IN
        Fisher_NNP did_VBD a_DT detailed_VBN evaluation_NN of_IN a_DT set_NN of_IN patients_NNS with_IN
        fibromyalgia_NN who_WP fit_VBP the_DT detailed_VBN pattern_NN of_IN 
        Rhus_NNP tox_NN ._. using_VBG expert_NN homeopathic_JJ
        methods_NNS ._. A_DT randomized_JJ controlled_VBN trial_NN in_IN this_DT group_NN showed_VBD
        increased_VBN effects_NNS of_IN 
        Rhus_NNP tox_NN over_IN placebo_NN ._. [_NN 14_CD ]_NN
        These_DT differing_VBG frameworks_NNS also_RB complicate_VB our_PRP$ ability_NN
        to_TO comparatively_RB evaluate_VB these_DT systems_NNS ._. [_NN 7_CD 8_CD 9_CD 10_CD 11_CD ]_NN
        The_DT lack_NN of_IN support_NN for_IN homeopathic_JJ therapies_NNS among_IN Western_JJ
        practitioners_NNS stems_VBZ ,_, in_IN part_NN ,_, from_IN the_DT scarce_JJ quantity_NN and_CC
        perceived_VBN poor_JJ quality_NN of_IN homeopathic_JJ clinical_JJ research_NN ._.
        However_RB ,_, no_DT studies_NNS have_VBP directly_RB compared_VBN the_DT quality_NN of_IN
        research_NN in_IN homeopathic_JJ to_TO conventional_JJ medicine_NN using_VBG a_DT
        quality_NN assessment_NN method_NN that_WDT is_VBZ neutral_JJ to_TO their_PRP$
        differing_VBG diagnostic_JJ classifications_NNS ,_, treatment_NN and_CC outcome_NN
        strategies_NNS ._. A_DT meta-analysis_JJ of_IN homeopathic_JJ clinical_JJ trials_NNS
        (_( on_IN which_WDT WJ_NNP was_VBD the_DT corresponding_JJ author_NN )_) evaluated_VBD some_DT
        specific_JJ quality_NN parameters_NNS of_IN 89_CD placebo-controlled_JJ trials_NNS
        of_IN homeopathy_NN using_VBG commonly_RB used_VBN methods_NNS for_IN addressing_VBG
        conventional_JJ medical_JJ studies_NNS ._. [_NN 5_CD ]_NN This_DT study_NN reported_VBD
        that_IN homeopathic_JJ clinical_JJ trials_NNS scored_VBD about_IN the_DT same_JJ as_IN
        conventional_JJ trials_NNS on_IN the_DT Jadad_NNP scale_NN of_IN quality_NN
        assessment_NN ._. The_DT Jadad_NNP scale_NN contains_VBZ only_RB 5_CD items_NNS ,_, however_RB ,_,
        and_CC measures_VBZ simple_JJ components_NNS of_IN internal_JJ validity_NN ._. [_NN 15_CD ]_NN
        No_DT information_NN about_IN external_JJ validity_NN ,_, generalizability_NN ,_,
        statistical_JJ validity_NN ,_, effects_NNS when_WRB compared_VBN to_TO conventional_JJ
        treatments_NNS ,_, and_CC other_JJ important_JJ trial_NN quality_NN items_NNS were_VBD
        assessed_VBN ._.
        When_WRB doing_VBG this_DT meta-analysis_JJ ,_, it_PRP became_VBD clear_JJ to_TO us_PRP
        that_IN using_VBG review_NN criteria_NNS based_VBN on_IN diagnostic_JJ
        classifications_NNS developed_VBN for_IN assessing_VBG conventional_JJ
        medicine_NN did_VBD not_RB address_VB the_DT differing_VBG classification_NN
        frameworks_NNS between_IN homeopathy_NN and_CC conventional_JJ medicine_NN ._.
        There_EX were_VBD practically_RB no_DT studies_NNS that_WDT addressed_VBD both_DT
        classification_NN schemes_NNS and_CC very_RB few_JJ that_IN preselected_JJ a_DT
        uniform_NN set_NN of_IN patients_NNS according_VBG to_TO homeopathic_JJ criteria_NNS
        before_IN testing_VBG (_( as_IN in_IN the_DT Fisher_NNP trial_NN described_VBD above_IN )_) ._.
        This_DT resulted_VBD in_IN a_DT heterogeneity_NN problem_NN ,_, that_WDT is_VBZ ,_, we_PRP were_VBD
        mixing_VBG very_RB different_JJ types_NNS of_IN conditions_NNS and_CC
        classifications_NNS but_CC reviewing_VBG them_PRP from_IN the_DT perspective_NN of_IN
        one_CD of_IN these_DT classification_NN systems_NNS ._. This_DT problem_NN was_VBD not_RB
        solvable_JJ by_IN using_VBG narrow_JJ review_NN criteria_NNS created_VBN for_IN one_CD
        (_( conventional_JJ )_) system_NN ._. What_WP was_VBD needed_VBN was_VBD a_DT set_NN of_IN valid_JJ
        quality_NN criteria_NNS that_WDT were_VBD neutral_JJ to_TO these_DT two_CD systems_NNS
        with_IN very_RB different_JJ theoretical_JJ bases_NNS and_CC approaches_NNS ._. We_PRP
        felt_VBD that_IN an_DT evaluation_NN system_NN called_VBN "_'' Systematic_NNP Review_NNP "_''
        (_( SR_NNP )_) developed_VBN by_IN Light_NNP and_CC Pillemer_NNP [_NN 16_CD ]_NN provided_VBD such_JJ
        an_DT approach_NN since_IN the_DT review_NN criteria_NNS were_VBD not_RB depended_VBN on_IN
        diagnostic_JJ homogeneity_NN and_CC so_RB address_VB quite_RB disparate_JJ
        frameworks_NNS ._. SR_NNP is_VBZ comprehensive_JJ ,_, objective_NN and_CC validated_JJ
        quality_NN assessment_NN method_NN yet_RB also_RB with_IN broad_JJ in_IN
        applicability_NN ._. It_PRP was_VBD originally_RB derived_VBN and_CC extensively_RB
        applied_VBN to_TO heterogeneous_JJ systems_NNS of_IN intervention_NN in_IN the_DT
        social_JJ ,_, educational_JJ and_CC behavioral_JJ sciences_NNS but_CC has_VBZ since_IN
        been_VBN expanded_VBN to_TO the_DT evaluation_NN of_IN medicine_NN -_: both_DT
        conventional_JJ and_CC complementary_JJ ._. [_NN 17_CD 18_CD 19_CD ]_NN It_PRP allows_VBZ for_IN
        a_DT comprehensive_JJ assessment_NN of_IN research_NN quality_NN across_IN a_DT
        variety_NN of_IN study_NN designs_NNS and_CC intervention_NN areas_NNS ._.
        In_IN SR_NNP ,_, the_DT methodological_JJ characteristics_NNS critical_JJ for_IN
        attaining_VBG reliable_JJ and_CC valid_JJ research_NN results_NNS are_VBP evaluated_VBN
        across_IN a_DT variety_NN of_IN studies_NNS and_CC study_NN designs_NNS ._. By_IN
        quantitatively_RB evaluating_VBG components_NNS of_IN research_NN design_NN ,_,
        statistical_JJ methods_NNS ,_, generalizability_NN ,_, bias_NN and_CC related_VBN
        findings_NNS ,_, SRs_NNP provide_VB an_DT estimate_NN of_IN over_IN 30_CD quality_NN
        variables_NNS in_IN a_DT study_NN set_VBN ._. Collectively_RB ,_, these_DT criteria_NNS are_VBP
        referred_VBN to_TO as_IN "_'' threats_NNS to_TO validity_NN ._. "_'' In_IN addition_NN to_TO
        providing_VBG a_DT comprehensive_JJ assessment_NN of_IN quality_NN the_DT
        systematic_JJ evaluation_NN of_IN scientific_JJ methods_NNS provides_VBZ a_DT
        framework_NN from_IN which_WDT future_JJ studies_NNS can_MD be_VB designed_VBN ._. In_IN
        addition_NN to_TO its_PRP$ application_NN in_IN the_DT social_JJ and_CC behavioral_JJ
        sciences_NNS ,_, SRs_NNP have_VBP been_VBN successfully_RB applied_VBN to_TO
        conventional_JJ and_CC complementary_JJ medical_JJ approaches_NNS including_VBG
        nursing_NN care_NN [_NN 19_CD ]_NN ,_, religion_NN and_CC mental_JJ health_NN research_NN [_NN
        17_CD ]_NN ,_, abortion_NN [_NN 18_CD ]_NN ,_, and_CC physiotherapy_NN ._. Because_IN it_PRP
        provides_VBZ an_DT approach_NN to_TO the_DT evaluation_NN of_IN disparate_JJ
        systems_NNS ,_, we_PRP used_VBD the_DT SR_NNP method_NN to_TO evaluate_VB a_DT sample_NN of_IN
        homeopathic_JJ clinical_JJ trials_NNS and_CC compare_VB them_PRP to_TO the_DT quality_NN
        of_IN research_NN in_IN conventional_JJ studies_NNS previously_RB evaluated_VBN by_IN
        the_DT SR_NNP method_NN [_NN 20_CD ]_NN ._. Our_PRP$ specific_JJ aim_NN was_VBD to_TO get_VB
        representative_NN samples_NNS of_IN the_DT "_'' best_JJS "_'' research_NN in_IN both_DT
        homeopathy_NN and_CC conventional_JJ medicine_NN and_CC objectively_RB
        evaluate_VB their_PRP$ quality_NN using_VBG a_DT "_'' system_NN neutral_JJ "_'' approach_NN to_TO
        research_VB assessment_NN ._.
      
      
        Methods_NNP
        
          Literature_NNP search_NN
          A_DT multiple_JJ strategy_NN search_NN was_VBD undertaken_VBN to_TO identify_VB
          research_NN on_IN homeopathic_JJ treatments_NNS that_WDT used_VBD the_DT strategy_NN
          from_IN the_DT comprehensive_JJ review_NN by_IN Linde_NNP ,_, et_CC al_NN ._. [_NN 5_CD ]_NN
          Briefly_NNP ,_, this_DT involved_JJ 1_LS )_) the_DT review_NN by_IN Kleijnen_NNP ,_, et_CC al_NN ._.
          published_VBN in_IN 1991_CD ,_, [_NN 4_CD ]_NN which_WDT used_VBD a_DT extensive_JJ search_NN
          strategy_NN for_IN Medline_NNP and_CC Embase_NNP up_IN to_TO 1990_CD ;_: 2_LS )_) a_DT direct_JJ
          search_NN of_IN Medline_NNP from_IN 1966_CD to_TO August_NNP 1995_CD using_VBG the_DT full_JJ
          text_NN terms_NNS homeop_NN *_NN ,_, homoeop_NN *_NN ,_, and_CC the_DT Mesh_NNP terms_NNS
          homoeopathy_NN ,_, homoeopathy_NN ,_, and_CC alternative_JJ medicine_NN and_CC
          screening_NN of_IN all_DT citations_NNS found_VBD ;_: 3_LS )_) contacts_NNS with_IN
          homeopathic_JJ researchers_NNS ,_, institutions_NNS reporting_VBG on_IN
          homeopathic_JJ research_NN ,_, homeopathic_JJ manufacturers_NNS and_CC
          follow-up_JJ on_IN suggestions_NNS from_IN these_DT contacts_NNS ;_: 4_LS )_)
          searching_VBG several_JJ extensive_JJ homeopathic_JJ and_CC complementary_JJ
          medicine_NN registries_NNS including_VBG those_DT of_IN the_DT Woodward_NNP
          Foundation_NNP (_( USA_NNP )_) ;_: CISCOM_NNP (_( RCCM_NNP ,_, London_NNP )_) ;_: AMED_NNP (_( British_NNP
          Library_NNP )_) ;_: HomInform_NNP (_( Glasgow_NNP ,_, Scotland_NNP )_) ;_: IDAG_NNP
          (_( Amersfoort_NNP ,_, Netherlands_NNP )_) ;_: and_CC CCRH_NNP (_( India_NNP )_) as_RB well_RB as_IN
          several_JJ individual_JJ collections_NNS ;_: 5_LS )_) attending_VBG homeopathic_JJ
          meetings_NNS and_CC searching_VBG the_DT conference_NN proceedings_NNS ,_,
          abstract_JJ ebooklets_NNS ,_, and_CC indexes_NNS from_IN meetings_NNS and_CC
          homeopathic_JJ books_NNS ;_: 6_CD )_) the_DT references_NNS of_IN reviews_NNS and_CC
          trials_NNS found_VBD ;_: 7_CD )_) and_CC additional_JJ on-line_JJ searches_NNS of_IN
          Medline_NNP and_CC Embase_NNP from_IN 1989_CD to_TO October_NNP 1995_CD ._. We_PRP
          operationally_RB defined_VBD homeopathic_JJ research_NN as_IN studies_NNS
          involving_VBG serially_RB prepared_VBN dilutions_NNS selected_VBD according_VBG
          to_TO commonly_RB used_VBN methods_NNS ,_, including_VBG classical_JJ ,_, clinical_JJ ,_,
          and_CC complex_JJ approaches_NNS including_VBG pathological_JJ and_CC
          isopathic_JJ and_CC tautapathic_JJ remedy_NN selection_NN ._.
        
        
          Study_NN selection_NN
          We_PRP sought_VBD to_TO get_VB representative_NN samples_NNS of_IN the_DT best_JJS
          research_NN in_IN homeopathy_NN and_CC conventional_JJ medicine_NN ._. There_EX
          is_VBZ a_DT large_JJ disparity_NN in_IN the_DT amount_NN of_IN research_NN in_IN
          conventional_JJ and_CC homeopathic_JJ medicine_NN ._. In_IN addition_NN ,_, there_EX
          are_VBP recognized_VBN journals_NNS in_IN conventional_JJ medicine_NN publish_VB
          the_DT best_JJS research_NN ,_, while_IN this_DT is_VBZ not_RB the_DT case_NN in_IN
          homeopathy_NN ._. We_PRP therefore_RB used_VBD different_JJ approaches_NNS to_TO
          identify_VB the_DT best_JJS articles_NNS in_IN these_DT databases_NNS as_IN follows_VBZ ._.
          For_IN homeopathy_NN ,_, articles_NNS had_VBD to_TO meet_VB the_DT following_JJ
          criteria_NNS :_: (_( 1_LS )_) use_NN of_IN a_DT homeopathic_JJ intervention_NN for_IN a_DT
          clinical_JJ condition_NN in_IN a_DT comparative_JJ trial_NN ;_: (_( 2_LS )_) assessment_NN
          of_IN the_DT outcome_NN of_IN the_DT intervention_NN using_VBG an_DT empirical_JJ
          measure_NN of_IN some_DT type_NN ;_: (_( 3_LS )_) be_VB prospective_JJ and_CC involve_VB a_DT
          parallel_JJ control_NN group_NN for_IN comparison_NN with_IN homeopathic_JJ
          treatment_NN ;_: (_( 4_LS )_) have_VBP sufficient_JJ information_NN reported_VBD for_IN
          us_PRP to_TO score_NN with_IN SR_NNP review_NN criteria_NNS ;_: (_( 5_LS )_) be_VB in_IN English_NNP ._.
          We_PRP included_VBD criterion_NN (_( 3_CD -_: studies_NNS in_IN parallel_JJ control_NN
          groups_NNS )_) because_IN there_EX is_VBZ a_DT vast_JJ literature_NN of_IN case_NN and_CC
          series_NN outcome_NN reports_NNS in_IN homeopathy_NN that_WDT are_VBP not_RB written_VBN
          for_IN purposes_NNS of_IN research_NN and_CC so_RB would_MD not_RB represent_VB the_DT
          "_'' gold_NN standard_JJ "_'' for_IN homeopathic_JJ research_NN ._.
        
        
          Evaluation_NNP of_IN study_NN quality_NN
          Each_DT article_NN was_VBD reviewed_VBN using_VBG an_DT established_VBN coding_VBG
          form_NN previously_RB used_VBD and_CC validated_JJ for_IN SRs_NNP to_TO assess_VB the_DT
          characteristics_NNS and_CC quality_NN of_IN empirical_JJ research_NN ._. [_NN 19_CD
          20_CD 21_CD ]_NN In_IN addition_NN ,_, we_PRP determined_VBD whether_IN the_DT primary_JJ
          study_NN outcome_NN (_( as_IN determined_VBN by_IN the_DT author_NN or_CC ,_, if_IN
          unclear_JJ ,_, selected_VBN by_IN the_DT primary_JJ reviewer_NN )_) was_VBD improved_VBN ,_,
          unchanged_JJ or_CC made_VBN worst_JJS by_IN homeopathic_JJ treatment_NN ._. All_DT
          articles_NNS were_VBD reviewed_VBN through_IN a_DT contract_NN by_IN a_DT person_NN
          specifically_RB trained_VBN in_IN the_DT SR_NNP method_NN ,_, and_CC has_VBZ experience_NN
          in_IN applying_VBG it_PRP to_TO a_DT variety_NN of_IN study_NN sets_NNS ._. This_DT reviewer_NN
          had_VBD no_DT previous_JJ experience_NN or_CC opinion_NN about_IN homeopathy_NN
          and_CC was_VBD hired_VBN to_TO apply_VB the_DT SR_NNP methods_NNS to_TO this_DT data_NNS set_VBN ._.
          In_IN addition_NN ,_, the_DT quality_NN of_IN these_DT reviews_NNS were_VBD checked_VBN
          for_IN reliability_NN and_CC accuracy_NN on_IN two_CD samples_NNS by_IN two_CD other_JJ
          authors_NNS who_WP have_VBP extensive_JJ experience_NN with_IN the_DT SR_NNP method_NN
          and_CC were_VBD also_RB neutral_JJ about_IN homeopathy_NN (_( RA_NNP and_CC JL_NNP )_) ._. All_DT
          criterion_NN are_VBP scored_VBN as_RB either_DT "_'' met_VBD "_'' if_IN the_DT quality_NN items_NNS
          was_VBD present_JJ and_CC adequate_JJ or_CC "_'' not_RB met_VBD "_'' if_IN the_DT quality_NN item_NN
          was_VBD either_CC missing_VBG or_CC inadequately_RB met_VBD ._. The_DT reliability_NN
          of_IN these_DT review_NN criteria_NNS was_VBD consistently_RB greater_JJR than_IN
          0_CD ._. 95_CD between_IN and_CC among_IN reviewers_NNS ._. Finally_RB ,_, we_PRP checked_VBD for_IN
          trends_NNS in_IN quality_NN of_IN the_DT homeopathic_JJ literature_NN over_IN time_NN
          by_IN analyzing_VBG studies_NNS separately_RB in_IN three_CD groups_NNS -_: those_DT
          published_VBN before_IN 1980_CD (_( n_NN =_SYM 17_CD )_) ,_, and_CC from_IN 1980_CD -_: 89_CD (_( n_NN =_SYM 29_CD )_)
          and_CC 1990_CD -_: 96_CD (_( n_NN =_SYM 13_CD )_) ._.
          The_DT quality_NN scores_NNS for_IN this_DT set_JJ of_IN homeopathic_JJ studies_NNS
          was_VBD compared_VBN with_IN a_DT random_JJ sample_NN of_IN 100_CD articles_NNS
          previously_RB evaluated_VBN from_IN the_DT 
          New_NNP England_NNP Journal_NNP of_IN Medicine_NNP and_CC
          the_DT 
          Journal_NNP of_IN the_DT American_NNP Medical_NNP
          Association_NNP ._. [_NN 20_CD ]_NN JAMA_NNP and_CC the_DT NEJM_NNP are_VBP considered_VBN
          the_DT top_JJ two_CD journals_NNS in_IN conventional_JJ medical_JJ research_NN
          regardless_RB of_IN study_NN design_NN ._. In_IN addition_NN ,_, we_PRP had_VBD
          previously_RB evaluated_VBN this_DT set_JJ of_IN studies_NNS and_CC found_VBD it_PRP
          useful_JJ as_RB a_DT "_'' gold_NN standard_JJ "_'' for_IN conventional_JJ medicine_NN ._.
          This_DT sample_NN had_VBD identical_JJ inclusion_NN criteria_NNS to_TO the_DT
          homeopathic_JJ literature_NN except_IN they_PRP were_VBD not_RB required_VBN to_TO
          have_VB used_VBN a_DT parallel_JJ control_NN group_NN for_IN comparison_NN ._. This_DT
          aspect_NN of_IN study_NN design_NN is_VBZ assessed_VBN with_IN two_CD internal_JJ
          validity_NN criteria_NNS in_IN the_DT SR_NNP method_NN -_: "_'' selection_NN "_'' and_CC
          "_'' interaction_NN with_IN selection_NN "_'' -_: and_CC so_IN these_DT items_NNS were_VBD
          not_RB used_VBN to_TO compare_VB study_NN sets_NNS ._. All_DT other_JJ criteria_NNS
          operate_VBP independent_JJ of_IN a_DT control_NN group_NN design_NN and_CC so_RB
          allow_VB for_IN a_DT direct_JJ comparison_NN of_IN these_DT quality_NN items_NNS
          between_IN the_DT homeopathic_JJ and_CC conventional_JJ study_NN sets_NNS ._.
          Table_NNP 1_CD describes_VBZ the_DT criteria_NNS used_VBN in_IN the_DT SR_NNP method_NN ._.
          These_DT criteria_NNS have_VBP been_VBN extensively_RB validated_JJ and_CC found_VBD
          applicable_JJ to_TO a_DT variety_NN of_IN types_NNS of_IN empirical_JJ research_NN
          independent_JJ of_IN study_NN design_NN ._. [_NN 19_CD 20_CD 21_CD ]_NN
        
        
          Analysis_NNP
          Analysis_NNP consisted_VBD of_IN descriptive_JJ statistics_NNS for_IN both_DT
          sets_NNS of_IN studies_NNS and_CC a_DT comparison_NN of_IN outcomes_NNS in_IN those_DT
          studies_NNS randomized_JJ and_CC blinded_JJ to_TO those_DT that_WDT were_VBD not_RB
          using_VBG chi-square_JJ method_NN ._. In_IN addition_NN ,_, we_PRP compared_VBD the_DT
          number_NN and_CC percent_NN of_IN "_'' threats-to-validity_JJ "_'' in_IN both_DT
          homeopathic_JJ and_CC conventional_JJ data_NNS sets_NNS both_DT individually_RB
          and_CC in_IN their_PRP$ subgroups_NNS ._.
        
      
      
        Results_NNS
        
          Study_NN descriptions_NNS
          A_DT total_NN of_IN 59_CD empirical_JJ studies_NNS evaluating_VBG the_DT effects_NNS
          of_IN homeopathic_JJ interventions_NNS on_IN clinical_JJ conditions_NNS were_VBD
          included_VBN ._. (_( Table_NNP 2_LS )_) Forty-seven_NNP of_IN these_DT (_( 79_CD ._. 7_CD %_NN )_) were_VBD
          articles_NNS published_VBN in_IN peer-reviewed_JJ journals_NNS ._. Twelve_CD
          articles_NNS (_( 20_CD ._. 3_LS %_NN )_) were_VBD published_VBN as_IN proceedings_NNS ._. The_DT
          studies_NNS were_VBD published_VBN in_IN 22_CD different_JJ journals_NNS ,_, although_IN
          20_CD (_( 34_CD %_NN )_) were_VBD from_IN the_DT 
          British_NNP Homoeopathic_NNP Journal_NNP ._. Most_JJS
          studies_NNS (_( n_NN =_SYM 50_CD ,_, 84_CD ._. 7_CD %_NN )_) indicate_VBP no_DT funding_NN support_NN ,_,
          although_IN two_CD (_( 3_CD ._. 4_LS %_NN )_) were_VBD funded_VBN by_IN a_DT government_NN agency_NN
          and_CC seven_CD (_( 11_CD ._. 9_CD %_NN )_) stated_VBN they_PRP were_VBD funded_VBN by_IN a_DT private_JJ
          donor_NN /_NN foundation_NN ._.
        
        
          Subjects_NNP
          Across_IN all_DT studies_NNS that_WDT reported_VBD the_DT gender_NN of_IN
          subjects_NNS ,_, 60_CD %_NN of_IN subjects_NNS were_VBD female_JJ and_CC 40_CD %_NN male_JJ ._. Seven_CD
          studies_NNS (_( 11_CD ._. 9_CD %_NN )_) were_VBD entirely_RB female_JJ samples_NNS while_IN two_CD
          studies_NNS (_( 3_CD ._. 4_LS %_NN )_) were_VBD entirely_RB male_JJ samples_NNS ._. Nearly_RB half_NN of_IN
          all_DT studies_NNS (_( n_NN =_SYM 27_CD ;_: 45_CD ._. 8_CD %_NN )_) failed_VBD to_TO report_VB the_DT gender_NN
          of_IN subjects_NNS ._. No_DT study_NN indicated_VBD the_DT race_NN or_CC ethnicity_NN of_IN
          its_PRP$ sample_NN ._. Thirty-nine_NNP studies_NNS (_( 66_CD ._. 1_LS %_NN )_) indicated_VBD the_DT
          national_JJ origins_NNS of_IN the_DT sample_NN with_IN only_RB one_CD study_NN
          comprising_VBG subjects_NNS from_IN the_DT United_NNP States_NNPS (_( 1_CD ._. 7_CD %_NN )_) and_CC 38_CD
          studies_NNS comprising_VBG residents_NNS of_IN other_JJ countries_NNS (_( 64_CD ._. 4_LS %_NN )_) ._.
          The_DT average_JJ sample_NN size_NN was_VBD 2_CD ,_, 135_CD ;_: however_RB ,_, this_DT high_JJ
          average_JJ results_NNS from_IN a_DT single_JJ study_NN of_IN 18_CD ,_, 640_CD ._. The_DT median_JJ
          sample_NN size_NN was_VBD 59_CD ,_, with_IN a_DT range_NN from_IN 10_CD to_TO 934_CD
          (_( excluding_VBG the_DT outlier_NN )_) ._. Two_CD thirds_NNS of_IN studies_NNS (_( n_NN =_SYM 40_CD ;_:
          67_CD ._. 8_CD %_NN )_) had_VBD a_DT sample_NN size_NN below_IN 100_CD ._.
        
        
          Design_NNP
          All_DT studies_NNS were_VBD prospective_JJ and_CC used_VBD a_DT comparison_NN
          group_NN ._. Twenty-three_NNP studies_NNS (_( 40_CD %_NN )_) used_VBD a_DT placebo_NN control_NN ._.
          Thirty_NNP studies_NNS (_( 50_CD ._. 8_CD %_NN )_) used_VBN random_JJ assignment_NN between_IN
          experimental_JJ and_CC control_NN groups_NNS while_IN six_CD (_( 10_CD ._. 2_LS %_NN )_) used_VBD a_DT
          matched_VBN control_NN group_NN ._. Forty-nine_NNP studies_NNS (_( 83_CD ._. 1_LS %_NN )_) did_VBD not_RB
          describe_VB the_DT sampling_VBG frame_NN used_VBD ,_, that_WDT is_VBZ ,_, they_PRP did_VBD not_RB
          describe_VB how_WRB the_DT patient_NN sample_NN was_VBD identified_VBN ._. For_IN
          example_NN ,_, one_CD study_NN described_VBD the_DT method_NN for_IN random_JJ
          sampling_VBG ,_, four_CD studies_NNS used_VBD a_DT systematic_JJ sample_NN frame_NN
          (_( e_SYM ._. g_SYM ._. consecutive_JJ cases_NNS )_) ,_, one_CD study_NN used_VBD a_DT mixed_JJ frame_NN
          (_( e_SYM ._. g_SYM ._. random_JJ sampling_VBG of_IN consecutive_JJ cases_NNS )_) ,_, and_CC four_CD
          studies_NNS did_VBD not_RB use_VB a_DT sample_NN frame_NN (_( i_NNP ._. e_SYM ._. ,_, convenience_NN
          sampling_VBG )_) ._. Most_JJS studies_NNS (_( n_NN =_SYM 51_CD ,_, 86_CD ._. 4_LS %_NN )_) failed_VBD to_TO
          consider_VB potentially_RB confounding_VBG variables_NNS in_IN their_PRP$
          designs_NNS such_JJ as_IN open_JJ patient_NN selection_NN ,_, severity_NN of_IN
          illness_NN or_CC non-blind_JJ measurement_NN ._. Seven_CD studies_NNS explored_JJ
          potential_JJ confounds_NNS and_CC found_VBD none_NN ,_, while_IN only_RB one_CD study_NN
          explicitly_RB discussed_VBD potential_JJ confounds_NNS in_IN the_DT design_NN ._.
          The_DT proportion_NN of_IN studies_NNS in_IN which_WDT specific_JJ threats_NNS to_TO
          the_DT validity_NN of_IN causal_NN statements_NNS were_VBD identified_VBN can_MD be_VB
          found_VBN in_IN Table_NNP 3_CD ._.
        
        
          Measurement_NNP
          No_DT study_NN reported_VBD the_DT reliability_NN of_IN measures_NNS ._. Almost_RB
          all_DT studies_NNS failed_VBD to_TO report_VB response_NN rates_NNS ,_, that_WDT is_VBZ ,_, the_DT
          number_NN of_IN patients_NNS screened_VBD compared_VBN to_TO the_DT number_NN who_WP
          entered_VBD the_DT study_NN (_( n_NN =_SYM 57_CD ,_, 96_CD ._. 6_CD %_NN )_) ._. Of_IN the_DT two_CD studies_NNS
          that_WDT reported_VBD the_DT proportion_NN of_IN subjects_NNS approached_VBN who_WP
          participated_VBD ,_, the_DT average_JJ response_NN rate_NN was_VBD 36_CD ._. 5_LS %_NN ._. Nearly_RB
          two_CD thirds_NNS of_IN studies_NNS (_( n_NN =_SYM 38_CD ,_, 64_CD ._. 4_LS %_NN )_) did_VBD not_RB report_VB the_DT
          attrition_NN or_CC drop-out_JJ rate_NN ._. For_IN those_DT reporting_VBG this_DT
          item_NN ,_, an_DT average_NN of_IN 16_CD ._. 9_CD %_NN of_IN subjects_NNS began_VBD the_DT
          experiment_NN but_CC failed_VBD to_TO complete_VB it_PRP ._.
        
        
          Study_NNP Findings_NNP
          A_DT total_NN of_IN 229_CD outcome_NN variables_NNS were_VBD identified_VBN ,_, an_DT
          average_NN of_IN about_IN 4_CD outcomes_NNS per_IN study_NN ._. Of_IN these_DT ,_, 62_CD (_( 27_CD %_NN )_)
          were_VBD only_RB descriptive_JJ and_CC no_DT attempt_NN was_VBD made_VBN to_TO
          determine_VB how_WRB they_PRP were_VBD affected_VBN by_IN the_DT homeopathic_JJ
          treatment_NN ._. Seventy-three_NNP variables_NNS (_( 32_CD %_NN )_) were_VBD reported_VBN to_TO
          have_VB statistically_RB significant_JJ improvement_NN as_IN a_DT result_NN of_IN
          the_DT treatment_NN ._. Ninety_CD outcome_NN variables_NNS (_( 39_CD %_NN )_) were_VBD
          unaffected_JJ by_IN the_DT treatment_NN ,_, while_IN four_CD variables_NNS (_( 2_CD %_NN )_)
          were_VBD made_VBN significantly_RB worse_JJR by_IN the_DT treatment_NN ._.
          The_DT probability_NN of_IN a_DT positive_JJ outcome_NN was_VBD
          significantly_RB 
          lower_JJR when_WRB random_JJ assignment_NN was_VBD
          used_VBN than_IN when_WRB random_JJ assignment_NN was_VBD not_RB used_VBN (_( chi_NN
          square_JJ =_SYM 11_CD ._. 9_CD ,_, p_NN <_NN ._. 001_CD )_) a_DT finding_VBG often_RB found_VBD in_IN study_NN
          series_NN and_CC confirmed_VBN by_IN others_NNS in_IN homeopathic_JJ trials_NNS ._. [_NN
          12_CD ]_NN However_RB ,_, when_WRB the_DT homeopathic_JJ treatment_NN was_VBD compared_VBN
          to_TO a_DT conventional_JJ medical_JJ treatment_NN ,_, the_DT probability_NN of_IN a_DT
          positive_JJ outcome_NN was_VBD significantly_RB 
          higher_JJR than_IN when_WRB a_DT placebo_NN control_NN
          was_VBD used_VBN (_( chi_NN square_JJ =_SYM 15_CD ._. 3_LS ,_, p_NN <_NN ._. 0001_CD )_) ._.
        
        
          Overall_RB quality_NN
          Significant_JJ threats_NNS to_TO validity_NN occurred_VBD in_IN 30_CD -_: 40_CD %_NN of_IN
          studies_NNS in_IN every_DT major_JJ category_NN of_IN validity_NN measured_VBN ._.
          (_( Figure_NN 1_LS )_) Especially_RB high_RB were_VBD problems_NNS with_IN external_JJ
          validity_NN since_IN most_JJS studies_NNS had_VBD small_JJ sample_NN sizes_NNS and_CC
          few_JJ were_VBD multi-centered_JJ ._. Thus_RB ,_, the_DT results_NNS of_IN research_NN in_IN
          homeopathic_JJ medicine_NN is_VBZ less_RBR likely_JJ to_TO be_VB generalizable_JJ
          beyond_IN study_NN populations_NNS than_IN the_DT results_NNS of_IN research_NN in_IN
          conventional_JJ medicine_NN ._. Surprisingly_RB ,_, internal_JJ validity_NN
          quality_NN scores_NNS were_VBD very_RB similar_JJ between_IN homeopathic_JJ and_CC
          conventional_JJ studies_NNS ,_, indicating_VBG that_IN homeopathic_JJ
          research_NN is_VBZ not_RB appreciably_RB worse_JJR than_IN conventional_JJ
          research_NN when_WRB it_PRP comes_VBZ to_TO controlling_VBG for_IN bias_NN and_CC
          systematic_JJ error_NN ._. (_( Figure_NN 1_LS )_) Compared_VBN to_TO conventional_JJ
          studies_NNS using_VBG these_DT same_JJ quality_NN criteria_NNS the_DT homeopathic_JJ
          studies_NNS had_VBD a_DT higher_JJR number_NN of_IN validity_NN threats_NNS in_IN 21_CD
          categories_NNS (_( 63_CD ._. 6_CD %_NN )_) ,_, and_CC the_DT same_JJ in_IN 7_CD (_( 21_CD %_NN )_) categories_NNS ._.
          Conventional_JJ studies_NNS scored_VBD worse_JJR than_IN homeopathic_JJ
          studies_NNS in_IN 5_CD (_( 15_CD %_NN )_) categories_NNS ._. How_WRB homeopathic_JJ and_CC
          conventional_JJ studies_NNS compare_VBP on_IN all_DT validity_NN threats_NNS is_VBZ
          shown_VBN in_IN Table_NNP 3_CD ._. We_PRP were_VBD unable_JJ to_TO do_VB a_DT subset_NN analysis_NN
          of_IN conventional_JJ studies_NNS that_WDT used_VBD only_RB parallel_JJ control_NN
          groups_NNS in_IN order_NN to_TO confirm_VB the_DT independence_NN of_IN validity_NN
          threats_NNS from_IN study_NN design_NN in_IN this_DT sample_NN ._.
        
        
          Quality_JJ trends_NNS
          The_DT overall_JJ quality_NN scores_NNS in_IN homeopathic_JJ trials_NNS
          improved_VBN somewhat_RB from_IN 1945_CD to_TO 1995_CD ._. Cohort_NNP group_NN summary_NN
          scores_NNS went_VBD from_IN 30_CD %_NN total_JJ validity_NN threats_NNS in_IN studies_NNS
          done_VBN prior_RB to_TO 1980_CD (_( n_NN =_SYM 17_CD )_) ,_, to_TO 26_CD %_NN validity_NN threats_NNS
          between_IN 1980_CD -_: 1989_CD (_( n_NN =_SYM 29_CD )_) and_CC 24_CD %_NN between_IN 1990_CD and_CC 1996_CD
          (_( n_NN =_SYM 13_CD )_) (_( NS_NNP )_) ._.
        
      
      
        Discussion_NNP
        This_DT review_NN of_IN clinical_JJ outcome_NN research_NN in_IN homeopathy_NN
        has_VBZ several_JJ important_JJ implications_NNS for_IN the_DT field_NN not_RB
        revealed_VBD in_IN other_JJ reviews_NNS ._. Despite_IN the_DT absence_NN of_IN funding_NN ,_,
        it_PRP appears_VBZ that_IN a_DT number_NN of_IN prospective_JJ clinical_JJ trials_NNS

        using_VBG random_JJ assignment_NN and_CC control_NN group_NN designs_VBZ have_VBP been_VBN
        accomplished_VBN ._. The_DT results_NNS of_IN these_DT studies_NNS suggest_VBP that_IN ,_, in_IN
        general_JJ ,_, homeopathic_JJ treatments_NNS may_MD offer_VB some_DT promise_NN ,_,
        particularly_RB when_WRB compared_VBN to_TO conventional_JJ medical_JJ
        treatments_NNS ._. As_IN expected_VBN ,_, the_DT findings_NNS are_VBP less_RBR impressive_JJ
        when_WRB a_DT placebo_NN control_NN and_CC randomization_NN are_VBP used_VBN ._. This_DT
        pattern_NN may_MD reflect_VB the_DT placebo_NN influences_VBZ common_JJ to_TO both_DT
        conventional_JJ and_CC homeopathic_JJ therapies_NNS and_CC the_DT possibility_NN
        of_IN selection_NN bias_NN in_IN favor_NN of_IN homeopathy_NN for_IN many_JJ studies_NNS
        reported_VBD ._. Both_DT of_IN these_DT factors_NNS would_MD falsely_RB elevate_NN the_DT
        number_NN of_IN positive_JJ studies_NNS reported_VBD in_IN homeopathic_JJ
        research_NN ._. On_IN the_DT other_JJ hand_NN ,_, homeopathic_JJ physicians_NNS spend_VBP
        considerably_RB more_JJR time_NN per_IN visit_NN with_IN patients_NNS than_IN
        conventional_JJ physicians_NNS ._. [_NN 22_CD ]_NN The_DT comprehensive_JJ interview_NN
        and_CC long-term_JJ follow-up_JJ undertaken_VBN as_IN part_NN of_IN homeopathic_JJ
        case_NN management_NN increases_NNS patient-doctor_JJ interaction_NN and_CC
        likely_JJ enhances_VBZ expectancy_NN and_CC placebo_NN effects_NNS ._. This_DT may_MD
        make_VB it_PRP more_RBR difficult_JJ to_TO detect_VB and_CC isolate_VB any_DT additional_JJ
        effects_NNS from_IN homeopathic_JJ preparations_NNS ,_, if_IN these_DT occur_VB ._.
        Combined_VBN with_IN small_JJ sample_NN size_NN this_DT might_MD falsely_RB increase_VB
        the_DT number_NN of_IN negative_JJ studies_NNS reported_VBD ._. Thus_RB ,_, the_DT effect_NN
        of_IN the_DT homeopathic_JJ clinical_JJ process_NN needs_VBZ to_TO be_VB studied_VBN
        separately_RB from_IN the_DT examination_NN of_IN any_DT specific_JJ
        (_( non-placebo_JJ )_) effects_NNS that_WDT might_MD occur_VB from_IN homeopathic_JJ
        drugs_NNS ._. The_DT former_NN should_MD be_VB examined_VBN in_IN pragmatic_JJ
        randomized_JJ trials_NNS that_WDT compare_VBP homeopathic_JJ with_IN standard_JJ
        therapy_NN and_CC the_DT later_RB should_MD be_VB examined_VBN using_VBG simple_JJ
        laboratory_NN or_CC clinical_JJ models_NNS that_WDT can_MD be_VB easily_RB repeated_VBN
        by_IN independent_JJ investigators_NNS ._.
        This_DT study_NN has_VBZ several_JJ limitations_NNS ._. The_DT samples_NNS of_IN
        homeopathic_JJ and_CC conventional_JJ studies_NNS were_VBD not_RB identical_JJ ._.
        While_IN we_PRP took_VBD all_DT conditions_NNS in_IN both_DT study_NN samples_NNS ,_, we_PRP
        examined_VBD all_PDT the_DT English_NNP language_NN studies_NNS in_IN homeopathy_NN
        over_IN five_CD decades_NNS as_IN opposed_VBN to_TO more_RBR recent_JJ studies_NNS only_RB in_IN
        the_DT conventional_JJ literature_NN ._. In_IN addition_NN ,_, we_PRP selected_VBD only_RB
        studies_VBZ with_IN parallel_JJ control_NN groups_NNS in_IN homeopathy_NN but_CC took_VBD
        all_DT intervention_NN studies_NNS in_IN conventional_JJ medicine_NN ._. We_PRP did_VBD
        this_DT in_IN attempt_NN to_TO select_VB a_DT "_'' gold_NN standard_JJ "_'' sample_NN of_IN
        research_NN in_IN each_DT area_NN ._. While_IN this_DT difference_NN between_IN
        samples_NNS should_MD only_RB have_VB effected_JJ two_CD of_IN our_PRP$ 33_CD quality_NN
        criteria_NNS we_PRP cannot_NN be_VB sure_JJ that_IN other_JJ validity_NN scoring_VBG were_VBD
        not_RB effected_JJ ._. To_TO assess_VB the_DT relevance_NN of_IN these_DT sampling_VBG
        differences_NNS we_PRP examined_VBD only_RB the_DT more_RBR recent_JJ studies_NNS in_IN
        homeopathy_NN ._. Unfortunately_RB we_PRP were_VBD unable_JJ to_TO do_VB a_DT subset_NN
        analysis_NN of_IN only_RB conventional_JJ randomized_JJ ,_, placebo_NN
        controlled_VBD trials_NNS in_IN our_PRP$ conventional_JJ subset_NN in_IN order_NN to_TO
        confirm_VB the_DT independence_NN of_IN validity_NN threat_NN from_IN study_NN
        design_NN as_RB previously_RB shown_VBN ._. It_PRP is_VBZ likely_JJ that_IN this_DT would_MD
        have_VB further_RBR improved_VBN the_DT quality_NN scores_NNS of_IN the_DT
        conventional_JJ subset_NN ,_, however_RB ,_, which_WDT would_MD not_RB affect_VB our_PRP$
        main_JJ conclusions_NNS about_IN the_DT general_JJ quality_NN of_IN research_NN and_CC
        threats_NNS to_TO validity_NN in_IN these_DT two_CD systems_NNS ._.
        A_DT second_JJ limitation_NN is_VBZ that_IN the_DT Systematic_NNP Review_NNP method_NN
        used_VBN in_IN this_DT evaluation_NN is_VBZ derived_VBN from_IN the_DT social_JJ and_CC
        behavioral_JJ sciences_NNS and_CC is_VBZ not_RB commonly_RB used_VBN in_IN medical_JJ
        research_NN evaluation_NN ._. We_PRP selected_VBD this_DT system_NN ,_, however_RB ,_,
        precisely_RB because_IN it_PRP was_VBD broad_JJ enough_RB to_TO examine_VB disparate_JJ
        theoretical_JJ systems_NNS in_IN a_DT more_RBR even_RB handed_VBN manner_NN than_IN
        review_NN criteria_NNS developed_VBN specifically_RB for_IN use_NN in_IN a_DT
        biomedical_JJ framework_NN ._. While_IN the_DT SR_NNP method_NN has_VBZ been_VBN used_VBN in_IN
        conventional_JJ and_CC complementary_JJ medicine_NN evaluations_NNS in_IN the_DT
        past_JJ we_PRP realize_VBP that_IN the_DT system_NN can_MD only_RB help_VB make_VB general_JJ
        estimates_NNS of_IN comparative_JJ quality_NN and_CC that_IN individual_NN or_CC
        summary_NN scores_NNS between_IN the_DT two_CD systems_NNS should_MD not_RB be_VB viewed_VBN
        as_IN precise_JJ ._. Since_IN limitations_NNS in_IN score_NN precision_NN is_VBZ a_DT
        problem_NN with_IN all_DT such_JJ scoring_VBG methods_NNS we_PRP have_VBP tried_VBN to_TO
        highlight_VB only_RB the_DT general_JJ and_CC obvious_JJ validity_NN threats_NNS
        found_VBD ._.
        How_WRB do_VBP the_DT quality_NN issues_NNS in_IN homeopathic_JJ research_NN
        compare_VB with_IN conventional_JJ medical_JJ research_NN ?_. Overall_RB ,_, the_DT
        quality_NN of_IN homeopathic_JJ research_NN is_VBZ not_RB as_RB good_JJ as_IN research_NN
        in_IN conventional_JJ medicine_NN ._. The_DT quality_NN of_IN homeopathic_JJ trials_NNS
        has_VBZ only_RB slightly_RB improved_VBN over_IN time_NN ._. Homeopathic_NNP studies_NNS
        scored_VBD worse_JJR than_IN conventional_JJ studies_NNS on_IN validity_NN threats_NNS
        in_IN over_IN 60_CD %_NN of_IN the_DT items_NNS rated_VBN compared_VBN to_TO 15_CD %_NN of_IN the_DT items_NNS
        in_IN which_WDT convention_NN studies_NNS scored_VBD worse_JJR ._. Most_JJS of_IN these_DT
        errors_NNS were_VBD on_IN items_NNS that_WDT would_MD effect_VB the_DT generalizability_NN
        of_IN the_DT results_NNS to_TO other_JJ settings_NNS rather_RB than_IN on_IN failure_NN to_TO
        control_VB for_IN systematic_JJ errors_NNS within_IN studies_NNS (_( bias_NN )_) ._.
        Several_JJ quality_NN issues_NNS are_VBP similar_JJ between_IN homeopathic_JJ and_CC
        conventional_JJ studies_NNS ._. Notably_RB ,_, both_DT groups_NNS of_IN research_NN
        consistently_RB fail_VB to_TO report_VB on_IN the_DT reliability_NN of_IN measures_NNS
        used_VBN ._. Unreliable_NNP outcome_NN measures_NNS can_MD markedly_RB distort_VB the_DT
        accuracy_NN and_CC value_NN of_IN statistical_JJ analysis_NN and_CC
        interpretation_NN of_IN the_DT results_NNS ._. For_IN example_NN ,_, one_CD otherwise_RB
        very_RB well_RB done_VBN study_NN reported_VBD on_IN the_DT rates_NNS of_IN tonsillectomy_NN
        under_IN classical_JJ homeopathic_JJ versus_CC placebo_NN treatment_NN as_IN a_DT
        main_JJ outcome_NN even_RB though_IN the_DT reliability_NN of_IN clinical_JJ
        decisions_NNS for_IN obtaining_VBG tonsillectomy_NN are_VBP extremely_RB poor_JJ ,_,
        thus_RB ,_, making_VBG this_DT comparison_NN meaningless_JJ ._. [_NN 23_CD ]_NN
        Currently_RB ,_, the_DT greatest_JJS weaknesses_NNS in_IN homeopathic_JJ
        research_NN are_VBP the_DT variety_NN of_IN unreplicated_JJ studies_NNS and_CC the_DT
        small_JJ sample_NN sizes_NNS ._. Although_IN 59_CD studies_NNS were_VBD included_VBN ,_,
        there_EX was_VBD virtually_RB no_DT replication_NN and_CC practically_RB no_DT
        overlap_VB in_IN the_DT conditions_NNS studied_VBN ._. Two_CD thirds_NNS of_IN the_DT
        studies_NNS had_VBD total_JJ sample_NN sizes_NNS below_IN 100_CD and_CC many_JJ did_VBD not_RB
        do_VB power_VB calculations_NNS to_TO determine_VB the_DT required_JJ subject_JJ
        numbers_NNS ._. In_IN order_NN to_TO build_VB credibility_NN within_IN the_DT medical_JJ
        research_NN field_NN ,_, multiple_JJ replications_NNS and_CC /_NN or_CC extensions_NNS
        using_VBG the_DT same_JJ or_CC similar_JJ approaches_NNS to_TO treat_VB the_DT same_JJ or_CC
        similar_JJ medical_JJ conditions_NNS are_VBP necessary_JJ ._. Similarly_RB ,_,
        multi-site_JJ research_NN with_IN larger_JJR sample_NN sizes_NNS is_VBZ essential_JJ
        to_TO improve_VB the_DT confidence_NN and_CC generalizability_NN of_IN findings_NNS ._.
        As_IN in_IN all_DT of_IN medicine_NN ,_, success_NN in_IN a_DT treatment_NN at_IN one_CD site_NN
        often_RB does_VBZ not_RB always_RB translate_VB into_IN success_NN at_IN other_JJ
        locations_NNS with_IN different_JJ practitioners_NNS and_CC patients_NNS ._. A_DT
        second_JJ major_JJ flaw_NN of_IN homeopathic_JJ studies_NNS in_IN many_JJ have_VBP a_DT
        high_JJ "_'' attrition_NN rate_NN ._. "_'' This_DT means_VBZ that_IN the_DT data_NNS analyzed_VBD
        and_CC reported_VBD on_IN is_VBZ often_RB lower_JJR than_IN the_DT entry_NN sample_NN size_NN
        due_JJ to_TO all_DT causes_NNS ,_, such_JJ as_IN dropouts_NNS ,_, lost_VBD or_CC incorrectly_RB
        filled_VBN out_RP forms_NNS ,_, etc_FW ._. A_DT high_JJ attrition_NN rate_NN can_MD be_VB a_DT major_JJ
        threat_NN to_TO validity_NN in_IN a_DT study_NN ._. In_IN addition_NN ,_, homeopathic_JJ
        studies_NNS often_RB demonstrated_VBD a_DT interaction_NN of_IN treatment_NN
        setting_NN and_CC treatment_NN indicating_VBG that_IN non-specific_JJ effects_NNS
        in_IN the_DT environment_NN more_RBR often_RB contributed_VBD to_TO the_DT outcome_NN
        than_IN in_IN conventional_JJ research_NN ._.
        Finally_RB ,_, several_JJ fairly_RB simple_JJ improvements_NNS in_IN the_DT
        reporting_NN of_IN research_NN findings_NNS can_MD help_VB to_TO heighten_VB the_DT
        quality_NN of_IN these_DT studies_NNS ._. Most_JJS importantly_RB ,_, an_DT outlined_VBN
        discussion_NN of_IN study_NN limitations_NNS and_CC potential_JJ confounders_NNS
        is_VBZ important_JJ for_IN a_DT balanced_JJ interpretation_NN of_IN results_NNS and_CC
        for_IN the_DT advancement_NN of_IN existing_VBG research_NN ._. Similarly_RB ,_, a_DT
        detailed_VBN description_NN of_IN sample_NN characteristics_NNS ,_, including_VBG
        gender_NN ,_, ethnicity_NN ,_, and_CC attrition_NN rates_NNS is_VBZ necessary_JJ for_IN
        determining_VBG generalizability_NN ._. By_IN precisely_RB delineating_VBG
        study_NN and_CC sample_NN characteristics_NNS ,_, research_NN findings_NNS can_MD be_VB
        stated_VBN more_RBR definitively_RB ._. The_DT absence_NN of_IN an_DT appropriate_JJ
        framework_NN from_IN which_WDT to_TO examine_VB homeopathic_JJ remedies_NNS is_VBZ one_CD
        but_CC not_RB the_DT sole_JJ challenge_NN to_TO quality_NN research_NN in_IN this_DT
        alternative_JJ practice_NN ._. Critical_JJ systematic_JJ review_NN of_IN these_DT
        studies_NNS identifies_VBZ a_DT number_NN of_IN areas_NNS for_IN improvement_NN ._.
        Quality_JJ guidelines_NNS for_IN conducting_VBG research_NN in_IN homeopathy_NN
        are_VBP published_VBN ._. [_NN 24_CD ]_NN More_RBR critical_JJ peer_VBP review_NN of_IN
        homeopathic_JJ studies_NNS that_WDT pay_VBP attention_NN to_TO these_DT and_CC other_JJ
        guidelines_NNS can_MD advance_VB quality_NN research_NN in_IN this_DT area_NN ._. Such_JJ
        criteria_NNS need_VBP to_TO be_VB carefully_RB addressed_VBN by_IN investigators_NNS if_IN
        the_DT quality_NN ,_, credibility_NN and_CC usefulness_NN of_IN research_NN in_IN
        homeopathy_NN is_VBZ to_TO improve_VB ._.
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
    
  
